mobileslotsfreespins|翰宇药业：利拉鲁肽制剂及多种GLP-1原料药签约订单金额合计近6亿元

News summary

Hanyu Pharmaceutical: The total signed order amount for liraglutide preparations and various GLP-1 APIs is nearly 600 million yuan. Securities Times e Company Newsmobileslotsfreespins, Hanyu Pharmaceutical said on the interactive platform today that as of today, the company's signed orders for liraglutide preparations and various GLP-1 APIs totaled nearly 600 million yuan, and somemobileslotsfreespins...

Newsletter text

Hanyu Pharmaceutical: The total contracted order value of liraglutide preparations and various GLP-1 raw materials is nearly 600 million yuan. According to Securities Times e Company, Hanyu Pharmaceutical said on the interactive platform today that as of today, the company's liraglutide preparations and various GLP-1 raw materials have signed orders totaling nearly 600 million yuan, and some orders have been shipped one after another; the preparation production base has obtained EU GMP certification and U.S. cGMP certification, and the API production base has passed Australia TGA-GMP certification and U.S. cGMP certification.

Tags：

转载：如非注明，本站文章均为 江西股票期货网 原创，转载请注明出处和附带mobileslotsfreespins|翰宇药业：利拉鲁肽制剂及多种GLP-1原料药签约订单金额合计近6亿元本文链接。